1.Progress of risk factors of allergic diseases
International Journal of Pediatrics 2016;43(5):382-388
In recent years,the incidence of allergic diseases is rising.The mild symptoms in allergic diseases are partial performance,but the severe symptoms in allergic diseases can induce anaphylactic shock and even death.With the unclear pathogenesis,there is lack of the effective treatment.Early detection and control of risk factors that cause allergic disease may be helpful in reducing the incidence of allergic disease.This review describes recent progress in the study of epidemiology, risk factors of allergic diseases, hypotheses of mechanism and the direction of future researches in risk factors of allergic diseases.
2.Rehabilitation Nursing for Hemicorporectomy: A Case Report
Chinese Journal of Rehabilitation Theory and Practice 2010;16(1):94-96
Hemicorporectomy, occasionally being varied as total pelvis resection, is the highest section in lower limb amputation. The nursing for a hemicorporectomy patient was reported.
3.SCGB3A2: A validated susceptibility gene to Graves' disease in different ethnic populations
Shuangxia ZHAO ; Huaidong SONG
Chinese Journal of Endocrinology and Metabolism 2013;(2):93-96
Graves' disease is a common autoimmune disease triggered by the susceptibility genes and environmental factors.Among the 9 risk genes related to Graves' disease,SCGB3A2 is the first Graves' disease-predisposing gene identified by our group using tagSNPs,strategy of candidate genes,and positional clones.The association between SCGB3A2 and Graves' disease has been confirmed by two independent cohorts from UK and Russia.So far,the geneticists on Graves' disease regard SCGB3A2 as a validated susceptibility gene of that disease.
4.Comparison of effects of carvedilol and motoprolol on the weight of cardiac muscle in patients with hypertensive heart disease
Clinical Medicine of China 2013;(6):594-596
Objective To observe the effect of carvedilol and motoprolol on the weight of cardiac muscle in patients with hypertensive heart disease.Methods One hundred patients with hypertensive heart disease were divided into two groups by random number and treated with carvedilol(n =54) and motoprolol(n =46) respectively for 12 months.Data were recorded (left ventricular end-diastolic dimension (LVEDD),left ventricular end-systolic dimension (LVESD),left ventricular ejection fraction (LVEF),interventricular septal thickness (IVST),and left ventricular posterior wall thickness (LVPWT)) before and after the treatment.Left ventricular muscle mass(LVW),left ventricular mass index(LVWI) were calculated.Results After treatment,both groups improved with declined LVEDD (motoprolol group:(43.60 ± 4.43) mm vs.(46.70 ± 3.21) mm,t =18.143,P < 0.01 ; carvedilol group:(42.50 ± 2.56) mm vs.(46.5 ± 3.18) mm,t =18.232,P < 0.01),thinner IVST (motoprolol group:(9.68 ± 1.65) mm vs.(12.01 ± 1.56) mm,t =12.785,P < 0.01 ; carvedilol group:(9.05 ± 1.04) mm vs.(11.59 ± 1.54) mm,t =7.865,P < 0.01),and increased LVEF (motoprolol group:(52.89 ± 8.78)% vs.(50.23 ± 7.88)%; carvedilol group:(54.65 ± 8.87%)% vs.(50.22 ±7.89)%).In the carvedilol treatment group,LVMI significantly (t =4.987,P < 0.01) declined from (133.75 ±25.89) g/m2 to (109.25 ± 22.53) g/m2.In the motoprolol treatment group,LVMI declined from (134.76 ± 25.87) g/m2 to (119.78 ± 23.65.53) g/m2 (t =5.689,P < 0.01).After the treatment,each index of carvedilol group improved significantly compared with metoprolol group (P < 0.05).Conclusion Both medications are able to reduce the weight of cardiac muscle of patients with hypertensive heart disease,and carvedilol is better than motoprolol.
5.The relationship between endocrine-metabolism system and the liver diseases
Chinese Journal of Endocrinology and Metabolism 2010;26(11):1009-1012
More and more studies suggest that endocrine-metabolic diseases and liver diseases influence each other. Endocrine-metabolic diseases may lead to abnormal liver function, and liver diseases are found also to cause disturbance of endocrine-metabolic system.
6.Analysis of clinical effect for children with obstructive sleep apnea hypopnea syndrome
Chinese Journal of Primary Medicine and Pharmacy 2008;15(10):1623-1624
Objective To investigate the causes and therapeutic method for children with obstructive sleep apnea hypopnea syndrome. Methods 72 patients with obstructive sleep apnea hypopnea syndrome were treated by adenctonsillectomy, operation and precaution of postoperation complication. Results 62 patients (86.1% )were cure.8 patients(11.1% ) were better. 2 patients(2.7% ) were no change. Conclusion The children with obstructive sleep apnea hypopnea syndrome caused by glandular organ and hypertrophyoftonsil, can improve the surgical results and late results.
7.Application of Jiao Xue on men's diseases.
Chinese Acupuncture & Moxibustion 2015;35(6):623-624
8.Simultaneous Determination of Multiple Bioactive Constituents in Total Alkaloid of Sophora alopecuroides by HPLC-DAD
Chinese Herbal Medicines 2011;03(1):66-69
Objective To develop a qualitative and quantitative simultaneous determination of multiple bioactive constituents in total alkaloid in Sophora alopecuroides (TASA). Methods In the experiment, a new and simple HPLC-DAD method for the simultaneous determination of multiple constituents in TASA was developed. The separation was performed on a Kromasil C,8 column (250mmx4.6mm,5.0pm) eluted with 0.02 mol/L potassium dihydrogen phosphate (adjusted pH 4.3 using 1% glacial acetic acid) and acetonitrile (75:25) at a flow-rate of 0.7 mUmin. The detection wavelength was set at 210 nn. Results Five constituents (sophoridine, matrine, oxymatnne, aloperme, and lehmamune) were simultaneously analyzed in this study. Four of them were identified and determinated by the developed method. The calibration curves exhibited linear regressions (r~2>0.9995). The injection precision, the intra-day precision, and the ana hsis repeatability were validated with the RSD values less than 5.0%. The mean recoveries of the four constituents were ranged from 98.62% to 100.20%, and the RSD values were all less than 3.37%. Conclusion This method is convenient, fast, accurate, and is applicable to analyze the multi-constituents in TASA.
9.The application of adrenal cortical hormone in the treatment of cerebral salt wasting syndrome
Chinese Journal of Postgraduates of Medicine 2016;39(12):1127-1130
Cerebral salt wasting syndrome (CSWS) is a common cause of refractory hyponatremia. Early diagnosis and treatment of CSWS can greatly improve the patient′s condition and improve the prognosis. Clinically by supplying sodium hydrate, most patients can resume normal serum sodium level, and get remission. But a few patients with low serum sodium, high urine sodium and low blood volume can not improve and even worse. Fludrocortisone and adrenal cortical hormone can rapidly and effectively reduce the urinary sodium level and urine volume, correct hyponatremia and low blood volume and improve the prognosis in such patients.
10.Simultaneous Determination of the Contents of 8 Ingredients of Shuanghuanglian Freeze-dried Powder in Pla-cental Perfusate
China Pharmacy 2015;(27):3823-3825
OBJECTIVE:To establish a method for the simultaneous determination of the contents of Shuanghuanglian freeze-dried powder in placental perfusate. METHODS:HPLC was performed on the column of Agilent Zorbax-C18 with mobile phase of acetonitrile-1%formic acid aqueous solution(gradient elution)at flow rate of 1.0 ml/min,the internal standard was puera-rin,detection wavelength was 280 nm,column temperature was 25 ℃ and sample volume was 10 μl. RESULTS:There was a lin-ear range between linear ranges and peak area of 8 ingredients(r≥0.999 0);RSDs of within-day and inter-day precision tests were no more than 1.9%,repeatability tests was no more than 7.3%;average recoveries were in the range of 92.73%-112.37%(RSD=3.2%-8.2%,n=6);and average matrix effects were 90.33%-105.78%(RSD=3.2%-8.0%,n=6). CONCLUSIONS:The method is rapid,sensitive and specific,and can be used to the simultaneous determination of the contents of 8 ingredients of Shuan-ghuanglian freeze-dried powder in placental perfusate.